RIO DE JANEIRO, RJ, São Paulo, SP (Fulhapres) – The COVID-19 vaccination and lower level of activity restrictions spurred the economic performance of many countries in the second quarter.
In a portion of the places with a record of resilience, gross domestic product (GDP) rose more than 4% compared to the first three months of 2021, data compiled by the Organization for Economic Co-operation and Development (OECD) indicates.
This is the case in Portugal and the United Kingdom. In this period, Portugal’s GDP rose by 4.9%, the highest increase in a list of nearly 30 countries. The increase followed a 3.2% drop in the previous quarter.
The UK emerged soon after, with an increase of 4.8% between April and June. There, the economy slumped 1.6% in the first three months of 2021.
On the OECD’s list, Japan was the poorest performing country, up 0.3%. Brazil was less than that. The national gross domestic product posted a negative 0.1% variance in the second quarter, according to data released Wednesday (1) by the IBGE.
According to data compiled by the Organization for Economic Co-operation and Development, Mexico was Latin America’s GDP with the main increase in the second quarter, at 1.5%. The other country in the region to appear on the list is Chile, an increase of 1% compared to the first three months of 2021.
The Organization for Economic Co-operation and Development (OECD) reports that the United States, the largest economy on Earth, had a gain of 1.6%. In addition to progressing in vaccination against Covid-19, the country also had a $1.9 trillion stimulus package, which President Joe Biden signed in March. China, the second world power, saw slightly lower growth, at 1.3%.
In recent weeks, the coronavirus has again spread signs of concern throughout the global economy. Fear was associated with delta variable prevalence.
In a report released in August, investment manager Rio Bravo drew attention to the matter. From the director’s point of view, the delta effects “promises to be deeper” than previously expected.
“Vaccination, which advanced rapidly around the world in the first half, has lost momentum in developed countries. Vaccination in the United States and Europe has reached 50% since mid-July. Surprisingly, it seems, there is such a large aversion to vaccines that it seems They affect about half of the population in these countries. This makes them more likely to suffer the effects of new mutations, as happens with the delta variant,” notes Rio Bravo.
